Evotec SE (EVO)
1.52
-0.06
(-3.80%)
USD |
NASDAQ |
Oct 30, 16:00
1.52
0.00 (0.00%)
After-Hours: 18:20
Evotec Enterprise Value : 572.94M for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 572.94M |
| October 28, 2026 | 581.82M |
| October 27, 2026 | 569.38M |
| October 26, 2026 | 551.63M |
| October 23, 2026 | 544.52M |
| October 22, 2026 | 558.73M |
| October 21, 2026 | 565.83M |
| October 20, 2026 | 537.42M |
| October 19, 2026 | 516.11M |
| October 16, 2026 | 501.90M |
| October 15, 2026 | 516.11M |
| October 14, 2026 | 517.88M |
| October 13, 2026 | 489.47M |
| October 12, 2026 | 498.35M |
| October 09, 2026 | 555.18M |
| October 08, 2026 | 569.38M |
| October 07, 2026 | 583.59M |
| October 06, 2026 | 590.70M |
| October 05, 2026 | 601.35M |
| October 02, 2026 | 580.04M |
| October 01, 2026 | 596.02M |
| September 30, 2026 | 619.11M |
| September 29, 2026 | 594.25M |
| September 28, 2026 | 576.49M |
| September 25, 2026 | 565.83M |
| Date | Value |
|---|---|
| September 24, 2026 | 555.18M |
| September 23, 2026 | 558.73M |
| September 22, 2026 | 572.94M |
| September 21, 2026 | 558.73M |
| September 18, 2026 | 580.04M |
| September 17, 2026 | 604.90M |
| September 16, 2026 | 590.70M |
| September 15, 2026 | 590.70M |
| September 14, 2026 | 608.45M |
| September 11, 2026 | 626.21M |
| September 10, 2026 | 640.42M |
| September 09, 2026 | 654.63M |
| September 08, 2026 | 658.18M |
| September 04, 2026 | 672.39M |
| September 03, 2026 | 686.59M |
| September 02, 2026 | 686.59M |
| September 01, 2026 | 651.08M |
| August 31, 2026 | 679.49M |
| August 28, 2026 | 690.15M |
| August 27, 2026 | 711.46M |
| August 26, 2026 | 704.35M |
| August 25, 2026 | 683.04M |
| August 24, 2026 | 683.04M |
| August 21, 2026 | 697.25M |
| August 20, 2026 | 707.90M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sartorius AG | 17.15B |
| SCHOTT Pharma AG & Co. KGaA | 3.920B |
| Thermo Fisher Scientific, Inc. | 297.65B |
| Agilent Technologies, Inc. | 53.27B |
| Bio-Rad Laboratories, Inc. | 10.03B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -54.24M |
| Revenue (Quarterly) | 166.82M |
| Total Expenses (Quarterly) | 221.06M |
| EPS Diluted (Quarterly) | -0.1526 |
| Gross Profit Margin (Quarterly) | -1.10% |
| Profit Margin (Quarterly) | -32.51% |
| Earnings Yield | -42.64% |
| Normalized Earnings Yield | -31.47 |